Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

https://doi.org/10.4081/itjm.2016.715

1452

PDF: 919

HTML: 341
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

1805

PDF: 239

HTML: 1
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

https://doi.org/10.4081/itjm.2024.1679

881

pdf: 415

HTML: 123
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

1952

PDF: 897

HTML: 1232
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

https://doi.org/10.4081/itjm.2016.649

1688

PDF: 1448

Appendix: 668

HTML: 544
Emergency management of patients being treated with oral anticoagulants

Franco Manzato, Massimo Franchini

234-241

17-12-2013

https://doi.org/10.4081/itjm.2013.234

1076

PDF: 841

HTML: 303
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.48

1368

PDF: 925
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

https://doi.org/10.4081/itjm.2014.450

1570

PDF: 1225

Appendix: 567

HTML: 622
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.1

10966

PDF: 2865
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.41

911

PDF: 791
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.29

1062

PDF: 831
Vorapaxar

Gianluca Airoldi, Mauro Campanini

88-95

24-04-2013

https://doi.org/10.4081/itjm.2013.88

1166

PDF: 641

HTML: 220
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.8

1307

PDF: 854
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

https://doi.org/10.4081/itjm.2023.1649

2489

PDF: 1012

HTML: 82
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.59

925

PDF: 900
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

25-11-2024

https://doi.org/10.4081/itjm.2024.1846

970

PDF: 342

SUPPLEMENTARY MATERIAL: 217

ACKNOWLEDGMENTS: 207

HTML: 104
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.74

1259

PDF: 870
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

https://doi.org/10.4081/itjm.2011.128

1165

PDF: 1843
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

https://doi.org/10.4081/itjm.2016.682

1892

PDF: 1095

HTML: 584
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.22

988

PDF: 729
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

https://doi.org/10.4081/itjm.2017.815

1325

PDF: 659

HTML: 265
Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

125-133

03-06-2014

https://doi.org/10.4081/itjm.2014.504

2098

PDF: 1312

Appendix: 1087

HTML: 756
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

https://doi.org/10.4081/itjm.2012.153

1674

PDF: 1974
Clinical characteristics of very old patients hospitalized in internal medicine wards for heart failure: a sub-analysis of the FADOI-CONFINE Study Group

Paolo Biagi, Roberto Nardi, Concetta Isabella Baldo, Giovanni Scanelli, Domenico Panuccio, Andrea Bonanome, Fabio Miserocchi, Luigi Lusiani, Erminio Bonizzoni, Mauro Campanini, Carlo Nozzoli, Giorgio Vescovo, on behalf of the FADOI-CONFINE Study Group

19-28

17-03-2014

https://doi.org/10.4081/itjm.2014.394

1999

PDF: 1101

HTML: 657
How to manage new oral anticoagulants in case of surgery

Davide Imberti

36-40

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.36

905

PDF: 811
Clinical management of spontaneous intracranial haemorrhage associated with oral anticoagulants: a case series

Luca Masotti, Alessandro Pampana, Paolo Pennati, Giancarlo Landini

34-44

07-03-2013

https://doi.org/10.4081/itjm.2011.34

759

PDF: 999
Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

184-190

14-06-2017

https://doi.org/10.4081/itjm.2017.705

1360

PDF: 733

HTML: 450
Sex differences in adverse drug reaction and liver disease

Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

15-22

20-03-2018

https://doi.org/10.4081/itjm.2018.893

2044

PDF: 868

HTML: 456
Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

Aurelio Seidita, Delia Sprini, Accursia BongiovÃ¬, Tiziana Catalano, Filippo Barbiera, Maria Accardi, Pasquale Mansueto, Antonio Carroccio

196-205

19-09-2013

https://doi.org/10.4081/itjm.2013.196

1852

PDF: 1053

HTML: 1910
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

https://doi.org/10.4081/itjm.2020.1296

795

PDF: 510

HTML: 361
Patent foramen ovale and ischemic stroke: more shadows than lights? What the internist should know

Andrea Donti

175-184

30-09-2016

https://doi.org/10.4081/itjm.2016.676

1582

PDF: 904

HTML: 924
Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

43-48

17-06-2020

https://doi.org/10.4081/itjm.2020.1224

929

PDF: 619

HTML: 183
Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

202-206

30-09-2016

https://doi.org/10.4081/itjm.2016.690

1638

PDF: 831

HTML: 803
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

https://doi.org/10.4081/itjm.2015.629

1592

PDF: 889

HTML: 254
The heart failure in Internal Medicine in Tuscany: the SMIT Study

Valerio Verdiani, Grazia Panigada, Alberto Fortini, Luca Masotti, Simone Meini, Paolo Biagi, for the SMIT Study Group

349-355

15-12-2015

https://doi.org/10.4081/itjm.2015.554

1622

PDF: 852

Appendix: 1005

HTML: 753
Differences in in-hospital clinical course, management and outcome between stroke with and without atrial fibrillation. A retrospective analysis from the SETI (Studio Epidemiologico Toscano Ictus) study

P. Biagi, S. Bocchini, R. Laureano, G. Panigada, G. Vescovo

14-22

03-05-2013

https://doi.org/10.4081/itjm.2007.4.14

989

PDF: 760
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

18-03-2021

https://doi.org/10.4081/itjm.2021.1351

1113

PDF: 524

HTML: 54
Acute severe renal failure in a patient receiving apixaban: a case report

Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

09-04-2024

https://doi.org/10.4081/itjm.2024.1718

579

PDF: 394

HTML: 69
The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

387-404

15-12-2015

https://doi.org/10.4081/itjm.2015.669

2087

PDF: 867

Appendix: 464

HTML: 1459
The management of the patient with acute pancreatitis: from evidence to clinical practice

Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

220-245

11-09-2017

https://doi.org/10.4081/itjm.2017.748

2683

PDF: 1174

HTML: 1338
Gender medicine: an up-date

Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

96-106

24-04-2013

https://doi.org/10.4081/itjm.2013.96

2107

PDF: 897

HTML: 471
Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

24-31

03-01-2019

https://doi.org/10.4081/itjm.2019.1111

1365

PDF: 755

HTML: 71
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

https://doi.org/10.4081/itjm.2018.1077

1477

PDF: 1747

HTML: 260
Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 3. Clinical issues

Roberto Nardi, Marco Masina, Giorgio Cioni, Paolo Leandri, Paola Zuccheri

99-109

08-05-2014

https://doi.org/10.4081/itjm.2014.400

2223

PDF: 1359

HTML: 717
Abdominal pain: a synthesis of recommendations for its correct management

Daniela Tirotta, Annalisa Marchetti, Mariangela Di Lillo, Fulvio Pomero, Roberta Re, Michele Meschi, Domenico Montemurro, Paola Gnerre, Chiara Bozzano, Micaela La Regina

193-202

08-05-2015

https://doi.org/10.4081/itjm.2015.515

3770

PDF: 1405

Appendix: 540

HTML: 8940
How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

20-11-2023

https://doi.org/10.4081/itjm.2023.1656

937

PDF: 306

HTML: 30
The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

Fernando Gallucci

16-02-2023

https://doi.org/10.4081/itjm.2023.1573

1866

PDF: 533

HTML: 13
An unusual cause of massive hemoptysis

Silvia Maestroni, Martino Cellerini, Antonio Brucato

71-74

01-07-2016

https://doi.org/10.4081/itjm.2016.738

1309

PDF: 835

HTML: 379
The management of the patient with non-variceal upper gastrointestinal bleeding: from evidence to clinical practice

Maddalena Zippi, Mariella Frualdo, Luciano Mucci, Marta Zanon, Chiara Marzano, Claudio Cassieri, Paola Gnerre, Pietro Crispino

246-252

27-12-2016

https://doi.org/10.4081/itjm.2016.713

1414

PDF: 942

HTML: 287
Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge

Marco Candela, Ruggero Pastorelli, Antonio Sacchetta, Mauro Campanini, Leonardo M. Fabbri, Carlo Nozzoli

218-230

19-09-2013

https://doi.org/10.4081/itjm.2013.218

1451

PDF: 1046

HTML: 854

1 - 50 of 52 items 1 2 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy